. LRRK2 Inhibitors as Promising Treatment for Parkinson's Disease. ACS Chem Neurosci. 2024 Nov 20;15(22):4092-4094. Epub 2024 Nov 2 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.